ArticleOncogene2020

EGFRvIII upregulates DNA mismatch repair resulting in increased temozolomide sensitivity of MGMT promoter methylated glioblastoma.

Nina Struve et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.